Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 151 - 200 out of 1,084

Document Document Title
WO/2001/068579
The invention relates to a method for producing 1,1' binaphthalenylidene-4,4'-diones of general formula (I), wherein R?1¿ represents C¿1-6? alkyl, C¿1-6? alkoxy, phenyl, substituted phenyl, benzyl or benzyloxy; R?2¿, R?3¿, R?4¿, an...  
WO/2001/054730
The invention relates to a method for producing a coenzyme Q10 / $g(g)-cyclodextrin complex. Said method is characterized in that a mixture of $g(g)-cyclodextrin and coenzyme Q10 is treated by homogenisation and inputting energy.  
WO/2001/046125
Substituted phenantheren-9, 10-diones in accord with structural diagram (I), compositions thereof and methods for the use thereof, for the treatment of T cell mediated conditions such as autoimmune diseases and organ graft rejection. In ...  
WO/2001/045681
Substituted naphthalenediones in accord with structural diagram (I): compositions thereof and methods for the use thereof, for the treatment of T cell mediated conditions such as autoimmune diseases and organ graft rejection. In compound...  
WO/2001/042243
Disclosed are compounds which inhibit or modulate the activity of protein kinases and pharmaceutical compositions containing such compounds. The disclosed compound contain two or more ligand moieties covalently linked together by one or ...  
WO/2001/026482
A composition, preferably used to reduce methane formation in a ruminant, wherein the composition is a combination of a polycyclic quinone compound and an ionophore compound.  
WO/2001/000554
Naphthoquinone derivatives of Formula (1): wherein, R represents an OH group, methyl ether, ethyl ether or a similar ether; R1 represents a methyl, ethyl or similar aliphatic hydrocarbon derivative; R2 and R3 each independently represent...  
WO/2000/066528
Novel quinones are provided, as well as compositions comprising these novel quinones. Methods of using the novel quinones in treatment of various indications including cancer are also provided.  
WO/2000/053655
The invention relates to conjugated polymers which contain triptycene units. According to the invention, the polymers are homopolymers made up of a repeating unit which contains a triptycenyl radical and copolymers made up of two or more...  
WO/2000/039064
New compounds of formula (I) are described, wherein n is > 1; X is O or NR¿4?; L is a n-valent linking group defined in claim 1 and R¿1? is H, halogen, C¿1?-C¿25?-alkyl, C¿3?-C¿25?-alkenyl, unsubstituted or by C¿1?-C¿4?-alkyl sub...  
WO/2000/023377
The invention concerns a novel method for preparing MEL-type titanium silicalite, the resulting product and its different uses in the field of catalysis. The inventive method for preparing MEL-type titanium silicalite is characterised in...  
WO/2000/008495
The present invention provides a compound selected from the group consisting of (I), (II), and (III), wherein R?1¿ and R?4¿ are the same or different and are each H, C¿1?-C¿3? alkyl, phosphate, or C¿1?-C¿3? alkyl carboxylate; R?2¿...  
WO/2000/002455
Hypericin has been shown to specifically inhibit T-type calcium channel activity. $i(Hypericum) extract containing hypericin also inhibits T-type calcium channel activity. Moreover, other chemicals in $i(Hypericum) extract showed a syner...  
WO/1999/061409
A compound which consists of a proactive alkylating moiety containing an electron-withdrawing group, a bioreductive moiety containing at least two double bonds, and a linker joining the proactive alkylating moiety and the bioreductive mo...  
WO/1999/052819
The invention relates to the anthraquinone cycle for producing hydrogen peroxide using at least two differently substituted 2-alkylanthraquinones and/or their tetrahydro derivatives. According to the inventive method, the working solutio...  
WO/1999/050434
The strain of the microorganism Penicillium oxalicum var. Armeniaca CCM 8242 produces an anthraquinonyl carboxylic acid derivative of structural formula (I), which may be used as a colorant, especially as a food colorant or cosmetic colo...  
WO/1999/048491
NF-$g(k)B inhibitors containing as the active ingredient benzoquinone derivatives represented by general formula (I), hydroquinone compounds thereof or salts of the same, wherein R¿1?, R¿2? and R¿3? independently represent each H, C¿...  
WO/1999/006347
Use of 1,3,4,6-tetrahydroxy-helianthrone and substituted derivative thereof as photoactivators for the photodynamic therapy of tumors. There are also provided novel substituted derivatives of 1,2,4,6-tetrahydroxy-helianthrone.  
WO/1998/039337
Process for synthesising pure enantiomer anthracycline. Compounds of formula (I) can be produced by using compounds of formulas (II) and (III).  
WO/1998/033758
A compound of formula (I), wherein R?1� and R?2� each represents a lower alkyl, or R?1� and R?2� may be bonded together to form a ring; X represents a spacer of which the number of atoms constituting the principal chain is 1 to 1...  
WO/1998/033757
The invention concerns a novel method for preparing substituted anthraquinone represented by the general formula (I) in which R represents a hydrogen atom or a linear or branched alkyl group of 1 to 5 carbon atoms, a chloromethyl group, ...  
WO/1998/023689
This invention relates to new blue anthraquinone colorants having Formula (I) wherein R and R�1? are the same or different and are selected from hydrogen and unsubstituted or substituted C1-C6 alkyl, C3-C7 cycloalkyl 2-furyl, 2-thienyl...  
WO/1998/012313
A transformant prepared by constructing a plasmid wherein a human-inducible nitric oxide synthase (hiNOS) structural gene has been substituted by a luciferase structural gene which is a reporter gene while sustaining the functions of the...  
WO/1998/008522
Multivitamin products targeted to specific groups.  
WO/1997/031936
A novel synthetic method, novel compounds formed using the synthetic method, and uses for the compounds so made are described. The synthetic method results in the formation of o-naphthoquinone derivatives. These compounds find use as pot...  
WO/1997/021684
The therapeutical use of tricyclic derivatives and pharmaceutically acceptable salts thereof having general formula (I), for treating diseases related to venous function deficiency and/or inflammatory oedema, is disclosed. In general for...  
WO/1997/016404
A novel method for preparing substituted anthraquinones of general formula (I), wherein R is hydrogen atom or a straight or branched C1-5 alkyl group, a chloromethyl group, a -COCl group, a -COOR' group or a -CH2OR' group where R' is a h...  
WO/1997/008262
This invention provides an aggregate of a compound capable of forming helical structures such that the aggregate is capable of achieving a specific rotation of at least 100,000� for plane polarized light having a wavelength of 589 nm.  
WO/1997/003940
The present invention relates to a novel 6-substituted-5,8-dioxy-1,4-naphthoquinone derivative having formula (I), which is useful as an anticancer agent. In said formula, R1 represents alkyl; R2 represents hydrogen, alkyl or acyl; and R...  
WO/1997/002271
This invention relates to certain naphthoquinone derivatives of general formula (1) or a salt thereof, in which m, n, R, R1, R2, R3, R4, R5, R6, R7, R8 are as defined in the description; processes for their preparation; compositions cont...  
WO/1997/000675
The use of the compounds of formula (I), wherein the groups are as defined in the disclosure, for the preparation of medicaments for the treatment of pathologies in which the erosion of the cartilaginous and bone matrix occurs.  
WO/1996/039130
Novel terpenoid-type quinones which can be obtained from Pycnanthus spp., processes for obtaining the novel terpenoid-type quinones and methods for their use as hypoglycemic agents, for example, in the treatment of diabetes are described...  
WO/1996/029297
A method of making a mesoporous silicate molecular sieve having a framework wall thickness of at least about 17 angstroms, comprising preparing solutions of neutral amine or diamine templating agents, neutral metal silicate precursors an...  
WO/1996/028410
A method comprising breaking down a complex of 2-(4'-ethylbenzoyl)benzoic acid, nHF and mBF3 to almost completely eliminate HF and BF3. The remaining solid is cyclised in concentrated sulphuric acid or oleum into non-pure 2-ethyl-anthraq...  
WO/1996/022075
The object of the invention is the use of diketo compounds of the formula (I) in which X is a saturated or unsaturated alkylene radical with 2 to 4 C atoms, which may be substituted by halogen, hydroxy, C1-C4 alkoxy, C1-C4 alkyl, C1-C4 h...  
WO/1996/021355
Pesticidal compounds having general formula (I) or a salt thereof is provided, in which n represents an integer from 0 to 4; m represents an integer 0 or 1; each R independently represents a halogen atom or a nitro, cyano, hydroxyl, alky...  
WO/1996/021354
Pesticidal as a pesticide against whitefly, Lepidoptera and certain fungi is provided of compound of general formula (I) or a salt thereof is provided, in which n represents an integer from 0 to 4; m represents an integer 0 or 1; each R ...  
WO/1996/010005
A process for catalytically dehydrogenating an anthrahydroquinone to form anthraquinone and a hydrogen product. A catalyst which is a metal, a metal compound, or a metal or metal compound dispersed on a support or is a liquid is selected...  
WO/1996/007731
A method for transfection of cultured mammalian cells is provided. Nucleic acid is mixed with polylysine and hypericin (or a hypericin analog), and a complex is formed. The complex is then contacted with cultured mammalian cells to deliv...  
WO/1996/004895
The present invention provides the new use in the treatment of amyloidosis with the anthracyclinone of formula (A) wherein R1, R2, R3, R4 and R5, are appropriate substituents. Some compounds of formula (A) are novel. Processes for their ...  
WO/1996/004230
Terpene-quinone with antitumor activity defined from a cyclocondensation reaction of Diels-Alder, used to obtain families or series of said compounds having a new structure and presenting a cytotoxic activity to cellular cultures P-388, ...  
WO/1996/004292
8-fluoro-anthracyclines of formula (I) having cis-stereochemistry between the groups 8-F and 9-OH, are described, such compounds present anti-tumor activity. Their preparation and pharmaceutical compositions containing them are also desc...  
WO/1995/032176
The invention relates to certain naphthoquinone derivatives, some of which are novel, of general formula (I) in which R represents a hydrogen atom or a hydroxyl or an ethanoyloxy group; methods for their preparation; compositions contain...  
WO/1995/030646
The present invention relates to compounds which are useful as sunscreens. The compounds persists on the skin for much longer than conventional sunscreens because they comprise a Michael acceptor linked directly or indirectly to a chromo...  
WO/1995/010266
A nitrogen monoxide synthesis inhibitor containing as the active ingredient at least one member selected from phenanthrene derivatives represented by the compounds of general formula (1) and salts thereof; it is useful for preventing and...  
WO/1995/005164
Particles of ubidecarenone or of other poorly water-soluble substances, optionally containing additives, characterized in that the poorly water-soluble substance which is solid, preferably crystalline, in the bulk phase, is at least part...  
WO/1995/002572
The present invention relates to a process for preparing 5,8-dihydronaphthoquinone derivatives represented by general formula (I) in which R1 represents alkyl or alkenyl, R2 represents hydrogen, alkyl or a group -C(O)R wherein R represen...  
WO/1994/017055
The present invention provides novel antiviral naphthoquinone compounds, which may be isolated from plants of the genus Conospermum or synthesized chemically, in accordance with the present inventive methods. The antiviral naphthoquinone...  
WO/1994/015258
A polymer has at least one photoactive site and more than one perfluorocyclobutane group. New monomers containing photoactive sites or photoactive precursors and at least one perfluorovinyl group are useful for making such polymers. Proc...  
WO/1994/014426
The invention relates to microfluidised particles of atovaquone and to a method of preparing them. More particularly, the invention is concerned with a pharmaceutical composition containing microfluidised particles of atovaquone which ha...  

Matches 151 - 200 out of 1,084